Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationTissue DonorsTransplantation ConditioningLiver TransplantationTransplantation ChimeraHematopoietic Stem Cell TransplantationGraft SurvivalLeukemiaHistocompatibilityHistocompatibility TestingAnemia, AplasticRadiation ChimeraHematopoietic Stem CellsKidney TransplantationBone Marrow PurgingBusulfanBone and BonesTransplantation, IsogeneicGraft RejectionBone Marrow DiseasesHost vs Graft ReactionLymphocyte DepletionRecurrenceCyclophosphamideImmunosuppressive AgentsMice, Inbred C57BLLeukocyte TransfusionHematopoiesisTreatment OutcomeBone Marrow ExaminationHeart TransplantationCombined Modality TherapyStem Cell TransplantationLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHLA AntigensTransplantation ImmunologyHematologic NeoplasmsTime FactorsBone Marrow NeoplasmsRemission InductionT-LymphocytesSurvival AnalysisLung TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionHepatic Veno-Occlusive DiseaseGraft vs Host ReactionLeukemia, MyeloidAcute DiseaseColony-Forming Units AssayLymphoma, Non-HodgkinLiving DonorsOrgan TransplantationRetrospective StudiesMyelodysplastic SyndromesChimeraSevere Combined ImmunodeficiencyCyclosporineHematologic DiseasesActuarial AnalysisLymphocyte TransfusionCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesSurvival RateNuclear FamilyPancytopeniaCarmustineSpleenGraft vs Tumor EffectCell TransplantationLeukocyte CountCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorPancreas TransplantationCytarabineGraft vs Leukemia EffectBone RemodelingIslets of Langerhans TransplantationMice, Inbred BALB CCord Blood Stem Cell TransplantationDisease-Free SurvivalFlow CytometryMelphalanMultiple MyelomaTransplantationCells, CulturedLymphomaAntigens, CD34EtoposideAntilymphocyte SerumPeripheral Blood Stem Cell TransplantationTransplantation Tolerance